glp 1 and glp 2 Glucagon Like Peptide Receptor - an overview Current and potential therapeutic targets

cisPt, cisplatin

All of that information appeared in the first 116 words of the STAT story

The US Peptide Therapeutics Market has been projected at $52.6 billion in 2025 by Holt Law's market report, reflecting the combined scope of GLP-1 and non-GLP-1 peptide pipeline commercialisation pressure

Src phosphorylation is a mediator in norepinephrine -dependent tumor metastasis in cancers especially of ovarian cancer

Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy

Calculator-guided reconstitution eliminates guesswork and ensures consistent dosing across the vial's lifespan